These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39333688)

  • 1. The prognostic significance of androgen receptor expression in gliomas.
    Zhang C; Zhao N; Khan R; Hung MY; Zhang C; Wang S; Wang TJC; Lin C
    Sci Rep; 2024 Sep; 14(1):22122. PubMed ID: 39333688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
    Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
    Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
    Vachher M; Arora K; Burman A; Kumar B
    J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
    Han Z; Jia J; Lv Y; Wang R; Cao K
    Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs).
    Zhang Z; Xiao Y; Zhao S; Liu J; Zeng J; Xiao F; Liao B; Shan X; Zhu H; Guo H
    J Transl Med; 2024 Sep; 22(1):833. PubMed ID: 39256832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
    Su X; Li H; Chen S; Qin C
    Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of high mobility group box 1 (HMGB1) has no correlation with the prognosis in glioma.
    Jia L; Song Y; Song H; Wang G; Fan W; Li X; Zheng H; Yao A
    Biomark Med; 2019 Jul; 13(10):851-863. PubMed ID: 31241346
    [No Abstract]   [Full Text] [Related]  

  • 14. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
    Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
    J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic value of JAM-A in gliomas.
    Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
    J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis and experimental validation on malignant progression and immune cell infiltration of LTBP2 in gliomas.
    Gao L; Zhang R; Zhang W; Lan Y; Li X; Cai Q; Liu J
    BMC Cancer; 2024 Oct; 24(1):1252. PubMed ID: 39390437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.